Given that ATF4 regulates the expression of NOXA, a known protein antagonist of MCL1, these findings further support the potential of modulating the ISR to therapeutically induce mitochondrial apoptosis in hematologic malignancies. This evidence concerns the gene PMAIP1 and hematologic disorder.